help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacDougall, E. D.
Right arrow Articles by Bornfeldt, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacDougall, E. D.
Right arrow Articles by Bornfeldt, K. E.
(American Journal of Pathology. 2006;168:2064-2073.)
© 2006 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2006.051009

Aggressive Very Low-Density Lipoprotein (VLDL) and LDL Lowering by Gene Transfer of the VLDL Receptor Combined with a Low-Fat Diet Regimen Induces Regression and Reduces Macrophage Content in Advanced Atherosclerotic Lesions in LDL Receptor-Deficient Mice

Erin D. MacDougall*, Farah Kramer{dagger}, Patti Polinsky{dagger}, Shelley Barnhart{dagger}, Bardia Askari{dagger}, Fredrik Johansson{dagger}, Rebecca Varon*, Michael E. Rosenfeld*, Kazuhiro Oka{ddagger}, Lawrence Chan{ddagger}, Stephen M. Schwartz{dagger} and Karin E. Bornfeldt{dagger}

From the Departments of Pathobiology* and Pathology,{dagger} University of Washington, Seattle, Washington; and the Department of Medicine,{ddagger} Baylor College of Medicine, Houston, Texas

Very low-density lipoprotein (VLDL) and LDL plasma levels are associated with cardiovascular mortality. Whereas VLDL/LDL lowering causes regression of early atherosclerotic lesions, less is known about the effects of aggressive lipid lowering on regression of advanced complex lesions. We therefore investigated the effect of VLDL/LDL lowering on pre-existing lesions in LDL receptor-deficient mice. Mice fed a high-fat diet for 16 weeks developed advanced lesions with fibrous caps, necrotic cores, and cholesterol clefts in the brachiocephalic artery. After an additional 14 weeks on a low-fat diet, plasma cholesterol levels decreased from 21.0 ± 2.6 to 8.4 ± 0.6 mmol/L, but lesions did not regress. Levels of VLDL/LDL were further lowered by using a helper-dependent adenovirus encoding the VLDL receptor (HD-Ad-VLDLR) under control of a liver-selective promoter. Treatment with HD-Ad-VLDLR together with a low-fat diet regimen resulted in reduced lesion size (cross-sectional area decreased from 146,272 ± 19,359 to 91,557 ± 15,738 µm2) and an 89% reduction in the cross-sectional lesion area occupied by macrophages compared to controls. These results show that aggressive VLDL/LDL lowering achieved by hepatic overexpression of VLDLR combined with a low-fat diet regimen induces regression of advanced plaques in the brachiocephalic artery of LDL receptor-deficient mice.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Johansson, F. Kramer, S. Barnhart, J. E. Kanter, T. Vaisar, R. D. Merrill, L. Geng, K. Oka, L. Chan, A. Chait, et al.
Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice
PNAS, February 12, 2008; 105(6): 2082 - 2087.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
P. Kotokorpi, E. Ellis, P. Parini, L.-M. Nilsson, S. Strom, K. R. Steffensen, J.-A. Gustafsson, and A. Mode
Physiological Differences between Human and Rat Primary Hepatocytes in Response to Liver X Receptor Activation by 3-[3-[N-(2-Chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propyloxy]phenylacetic Acid Hydrochloride (GW3965)
Mol. Pharmacol., October 1, 2007; 72(4): 947 - 955.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
X. SHEN and K. E. BORNFELDT
Mouse Models for Studies of Cardiovascular Complications of Type 1 Diabetes
Ann. N.Y. Acad. Sci., April 1, 2007; 1103(1): 202 - 217.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Schwartz, Z. S. Galis, M. E. Rosenfeld, and E. Falk
Plaque Rupture in Humans and Mice
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 705 - 713.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
C. L. Jackson, M. R. Bennett, E. A.L. Biessen, J. L. Johnson, and R. Krams
Assessment of Unstable Atherosclerosis in Mice
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 714 - 720.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. E. Kanter, F. Johansson, R. C. LeBoeuf, and K. E. Bornfeldt
Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques?
Circ. Res., March 30, 2007; 100(6): 769 - 781.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society for Investigative Pathology.